doi:10.1016/j.virs.2023.11.007

[1]
Yanjun Zhang, Haiyan Mao, Ju Li, Jianhua Li, Chen Huang, Jiaxuan Li, Minglei Chu, Fengbo Xue, Linhui Wang, Zhongbiao Fang, Zhen Wang, Jinan Wu, Keda Chen, 2023: Delta (B.1.617.2) inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques, Virologica Sinica, 38, 627-630. doi: 10.1016/j.virs.2023.05.009
[2]
Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu, Manli Wang, 2023: Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo, Virologica Sinica, 38, 257-267. doi: 10.1016/j.virs.2022.12.007
[3]
Jia Lu, Qiangling Yin, Rongjuan Pei, Qiu Zhang, Yuanyuan Qu, Yongbing Pan, Lina Sun, Ding Gao, Cuiqin Liang, Jingwen Yang, Wei Wu, Jiandong Li, Zongqiang Cui, Zejun Wang, Xinguo Li, Dexin Li, Shiwen Wang, Kai Duan, Wuxiang Guan, Mifang Liang, Xiaoming Yang, 2022: Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants, Virologica Sinica, 37, 238-247. doi: 10.1016/j.virs.2022.02.005
[4]
Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Hua-Jun Zhang, Yi-Wu Zhou, Ge Gao, Ying Chen, Yun Peng, Mei-Qin Liu, Ya-Nan Zhang, Juan Min, Jia Lu, Xiao-Xiao Gao, Jing Guo, Cheng Peng, Xu-Rui Shen, Qian Li, Kai Zhao, Lian Yang, Xin Wan, Bo Zhang, Wen-Hui Wang, Jia Wu, Peng Zhou, Xing-Lou Yang, Shuo Shen, Chao Shan, Zhi-Ming Yuan, Zheng-Li Shi, 2021: Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates, Virologica Sinica, 36, 879-889. doi: 10.1007/s12250-021-00376-w
[5]
Yuanyuan Qu, Xueyan Zhang, Meiyu Wang, Lina Sun, Yongzhong Jiang, Cheng Li, Wei Wu, Zhen Chen, Qiangling Yin, Xiaolin Jiang, Yang Liu, Chuan Li, Jiandong Li, Tianlei Ying, Dexin Li, Faxian Zhan, Youchun Wang, Wuxiang Guan, Shiwen Wang, Mifang Liang, 2021: Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants, Virologica Sinica, 36, 934-947. doi: 10.1007/s12250-021-00409-4
[6]
Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun, Haojie Zheng, Wei Wang, Erhei Dai, Yongzhe Li, 2023: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases, Virologica Sinica, 38, 723-734. doi: 10.1016/j.virs.2023.07.005
[7]
Hongming Huang, Jia Liu, 2023: Role of inactivated SARS-CoV-2 vaccine induced T cell responses in ameliorating COVID-19 severity, Virologica Sinica, 38, 324-326. doi: 10.1016/j.virs.2023.02.003
[8]
Jun Chen, Jing Yang, Fangfang Chang, Yabin Hu, Qian Wu, Shishan Teng, Yongchen Liu, Jian Zhang, Rongzhang He, Bo Liu, Xingyu Zheng, Ze Liu, Yanxi Peng, Zhenhua Xie, Yuanfang Zhang, Rui Lu, Dong Pan, You Wang, Liting Peng, Wenpei Liu, Yi-Ping Li, Xiaowang Qu, 2023: Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients, Virologica Sinica, 38, 313-316. doi: 10.1016/j.virs.2023.01.005
[9]
Haili Zhang, Hongli Jin, Feihu Yan, Yumeng Song, Jiaxin Dai, Cuicui Jiao, Yujie Bai, Jingxuan Sun, Di Liu, Shen Wang, Mengyao Zhang, Jilong Lu, Jingbo Huang, Pei Huang, Yuanyuan Li, Xianzhu Xia, Hualei Wang, 2023: An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV, Virologica Sinica, 38, 244-256. doi: 10.1016/j.virs.2022.12.006
[10]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[11]
Jing-Yu Wang, Tian-Ning Li, Chun-Lei Zhou, Jie Zhao, Meng Wang, Yuan Wang, Yan Jiang, He-Nan Dong, Qian-Ru Qi, Hong Mu, 2022: Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China, Virologica Sinica, 37, 850-859. doi: 10.1016/j.virs.2022.10.009
[12]
Mengyuan Chen, Jiaqin Xu, Lingjun Ying, Miaoguo Cai, Tao-Hsin Tung, Kai Zhou, Yufen Zheng, Xiaojie Bi, Jing Wang, Xi Tu, Bo Shen, Dongqing Lv, 2022: Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant: A single-center study in China, Virologica Sinica, 37, 842-849. doi: 10.1016/j.virs.2022.08.008
[13]
Wei Yang, Songliu Yang, Lei Wang, Yuxin Zhou, Yu Xin, Hongxu Li, Wenjing Mu, Qi Wu, Lei Xu, Mingyan Zhao, Changsong Wang, Kaijiang Yu, 2022: Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China, Virologica Sinica, 37, 704-715. doi: 10.1016/j.virs.2022.07.014
[14]
Mingqing Lu, Kunpeng Liu, Yun Peng, Zhe Ding, Yingwen Li, Alexander Tendu, Xue Hu, Ge Gao, Weiwei Guo, Hang Liu, Juhong Rao, Jiaxuan Zhao, Miaoyu Chen, Zhiming Yuan, Gary Wong, Chao Shan, Yanfeng Yao, Jiaming Lan, 2022: Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice, Virologica Sinica, 37, 581-590. doi: 10.1016/j.virs.2022.05.006
[15]
Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao, Jing Wang, Hanyu Pan, Jinlong Yang, Zhiming Liang, Yue Liang, Qinru Lin, Huitong Liang, Min Li, Jianping Liu, Yinzhong Shen, Xiaoyan Zhang, Pengfei Wang, Daru Lu, Chunhua Yin, Jianqing Xu, Shibo Jiang, Hongzhou Lu, Huanzhang Zhu, 2022: Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum, Virologica Sinica, 37, 831-841. doi: 10.1016/j.virs.2022.10.006
[16]
Xiaorui Xing, Lei Wang, Zhen Cui, Wangjun Fu, Tao Zheng, Lili Qin, Pingju Ge, Aidong Qian, Nan Wang, Shuai Yuan, 2022: Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants, Virologica Sinica, 37, 938-941. doi: 10.1016/j.virs.2022.11.003
[17]
Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002
[18]
Haiyan Shen, Yanxing Cai, Huan Zhang, Jie Wu, Lin Ye, Penghui Yang, Xiaojun Lin, Shibo Jiang, Ming Liao, 2021: Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19, Virologica Sinica, 36, 1080-1082. doi: 10.1007/s12250-021-00371-1
[19]
Pei Yu, Zijian Liu, Zhuoqi Zhu, Jiaqing Yang, Min Deng, Mingxiao Chen, Changchun Lai, Weiya Kong, Shilong Xiong, Li Wan, Weikang Mai, Lu Chen, Yu Lei, Shahzad Akbar Khan, Jianfeng Ruan, An Kang, Xuguang Guo, Qiang Zhou, Wenrui Li, Zheng Chen, Yuemei Liang, Pingchao Li, Lei Zhang, Tianxing Ji, 2023: Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees, Virologica Sinica, 38, 233-243. doi: 10.1016/j.virs.2022.12.008
[20]
Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan, Yaqi Ouyang, Shiying Yuan, Peng Zhou, You Shang, 2020: Correction to: Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak, Virologica Sinica, 35, 887-887. doi: 10.1007/s12250-020-00318-y